The United Laboratories International Holdings Ltd. is an investment company, which engages in the research, development, production and operation of medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company